Tonix Pharm Hldg (TNXP) Posts Q1 Loss of 59c/Share

Tonix Pharm Hldg (NASDAQ: TNXP) reported Q1 EPS of ($0.59), $0.24 worse than the analyst estimate of ($0.35).

For earnings history and earnings-related data on Tonix Pharm Hldg (TNXP) click here.

You May Also Be Interested In

• McDonald’s said to plan value strategy overhaul to revive US sales growth
• Brand Engagement Network files Cataneo financials after acquisition
• Piper Sandler Reiterates Overweight Rating on Block Inc. (XYZ)